Mark Capone
Director/Board Member presso DERMTECH, INC.
Patrimonio netto: 126 102 $ in data 31/03/2024
Profilo
Mark Christopher Capone founded Precision Medicine Advisors LLC in 2020, where he is working as Chief Executive Officer from 2020.
Mr. Capone also currently works at Mesa Laboratories, Inc., as Director from 2024, Owlstone Medical Ltd., as Non-Executive Director, Microba Life Sciences Ltd., as Non-Executive Director, DermTech, Inc., as Independent Director from 2022, and Nephrosant, Inc., as Independent Non-Executive Director from 2021.
Mr. Capone also formerly worked at Myriad Genetics, Inc., as President, Chief Executive Officer & Director from 2015 to 2020, Eli Lilly & Co., as Director-Area Sales, Abcam Plc, as Non-Executive Director, Myriad RBM, Inc., as Director, American Clinical Laboratory Association, as Director, Microba Life Sciences Ltd., as Non-Executive Director, Myriad Genetic Laboratories, Inc., as Chief Operating Officer from 2006 to 2010, and Pioneer Theatre Co., as Trustee.
Mr. Capone received his graduate degree in 1991 from Massachusetts Institute of Technology and undergraduate degree in 1984 from The Pennsylvania State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/11/2023 | 500 000 ( 0.11% ) | 68 500 $ | 31/03/2024 | |
DERMTECH, INC.
0.24% | 01/06/2023 | 82 054 ( 0.24% ) | 57 602 $ | 31/03/2024 |
MESA LABORATORIES, INC.
-.--% | 15/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Mark Capone
| Società | Posizione | Inizio |
|---|---|---|
| DERMTECH, INC. | Director/Board Member | 18/07/2022 |
| MESA LABORATORIES, INC. | Director/Board Member | 05/01/2024 |
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Director/Board Member | 16/02/2021 |
Precision Medicine Advisors LLC
 Precision Medicine Advisors LLC Miscellaneous Commercial ServicesCommercial Services Precision Medicine Advisors LLC provides educational programs around genomic. The private company is based in New York. The American company was founded by Mark Christopher Capone and he has been the CEO since incorporation. | Chief Executive Officer | 01/01/2020 |
Owlstone Medical Ltd.
 Owlstone Medical Ltd. Medical SpecialtiesHealth Technology Owlstone Medical Ltd. develops breathalyzer device for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease. The firm offers Lonestar VOC Analyzer, ReCIVA Breath Sampler and ultraFAIMS products. It also offers consult, analyze, and discover, report and validation services. The company was founded by Paul Boyle and Alonso David Ruiz in 2004 and is headquartered in Cambridge, CA. | Director/Board Member | - |
Precedenti posizioni note di Mark Capone
| Società | Posizione | Fine |
|---|---|---|
| MYRIAD GENETICS, INC. | Chief Executive Officer | 06/02/2020 |
Myriad Genetic Laboratories, Inc.
 Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Chief Executive Officer | 01/06/2015 |
| MICROBA LIFE SCIENCES LIMITED | Director/Board Member | - |
| ABCAM PLC | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Mark Capone
| Massachusetts Institute of Technology | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MESA LABORATORIES, INC. | Health Technology |
| MYRIAD GENETICS, INC. | Health Technology |
| ABCAM PLC | Health Technology |
| MICROBA LIFE SCIENCES LIMITED | Health Services |
| DERMTECH, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Myriad RBM, Inc.
 Myriad RBM, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT. | Commercial Services |
American Clinical Laboratory Association
 American Clinical Laboratory Association Miscellaneous Commercial ServicesCommercial Services American Clinical Laboratory Association is an organization that provides resources to its members who are involved in diagnostic innovation. The non-profit company is based in Washington. The American company works with patients and providers to meet the evolving healthcare needs of the country. | Commercial Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Commercial Services |
Pioneer Theatre Co.
 Pioneer Theatre Co. Media ConglomeratesConsumer Services Pioneer Theatre Co. operates performing arts theatres. The private company is based in Salt Lake City, UT. The company was founded in 1962. The CEO is Chris Lino. | Consumer Services |
Owlstone Medical Ltd.
Owlstone Medical Ltd. Medical SpecialtiesHealth Technology Owlstone Medical Ltd. develops breathalyzer device for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease. The firm offers Lonestar VOC Analyzer, ReCIVA Breath Sampler and ultraFAIMS products. It also offers consult, analyze, and discover, report and validation services. The company was founded by Paul Boyle and Alonso David Ruiz in 2004 and is headquartered in Cambridge, CA. | Health Technology |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Health Technology |
Precision Medicine Advisors LLC
Precision Medicine Advisors LLC Miscellaneous Commercial ServicesCommercial Services Precision Medicine Advisors LLC provides educational programs around genomic. The private company is based in New York. The American company was founded by Mark Christopher Capone and he has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Mark Capone
